NI
TNGX icon

Nextech Invest’s Tango Therapeutics TNGX Stock Holding History

Nextech Invest’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,266,081
Closed -$152M – 18
2026
Q1 		$152M Hold
7,266,081
– – 10.7% 3
2025
Q4 		$64.4M Buy
7,266,081
+1,732,101
+31% +$14.9M 6.22% 3
2025
Q3 		$46.5M Hold
5,533,980
– – 7.08% 4
2025
Q2 		$28.3M Hold
5,533,980
– – 5.36% 4
2025
Q1 		$7.58M Hold
5,533,980
– – 1.76% 11
2024
Q4 		$17.1M Hold
5,533,980
– – 2.77% 7
2024
Q3 		$42.6M Hold
5,533,980
– – 5.98% 5
2024
Q2 		$47.5M Hold
5,533,980
– – 7.99% 3
2024
Q1 		$43.9M Hold
5,533,980
– – 6.97% 6
2023
Q4 		$54.8M Hold
5,533,980
– – 10.21% 4
2023
Q3 		$62.3M Buy
+5,533,980
New +$33.7M 18.88% 2

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Nextech Invest's TNGX Position: Q2 2026 in Review

Nextech Invest sold out of Tango Therapeutics (TNGX) in Q2 2026, closing a stake of 7,266,081 shares — an estimated $152M sold.

Nextech Invest first reported a position in TNGX in Q3 2023 and held it in 11 quarters. The position peaked at $152M in Q1 2026. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Nextech Invest reported no remaining Tango Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Nextech Invest sold 7,266,081 Tango Therapeutics shares in Q2 2026, an estimated $152M.
  • Nextech Invest first reported a position in Tango Therapeutics in Q3 2023 and held it in 11 quarters.
  • Nextech Invest's Tango Therapeutics position peaked at $152M in Q1 2026.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Nextech Invest's 13F filing for Q2 2026, filed 14 Aug 2026.